More than 300,000 of Centinel Spine’s prodisc cervical and lumbar total disc replacement implantations have been performed worldwide.
The milestone marks over three decades of clinical use for the company’s prodisc-brand platform, according to a Nov. 13 news release.
Centinel Spine also highlighted recent regulatory and product milestones, including FDA approval for two-level indications of its prodisc L lumbar and prodisc C Vivo and SK cervical devices.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
